2.43
price down icon3.19%   -0.08
after-market アフターアワーズ: 2.41 -0.02 -0.82%
loading

Exagen Inc (XGN) 最新ニュース

pulisher
Oct 29, 2024

Exagen to Announce Third Quarter 2024 Results on November 12, 2024 - GlobeNewswire

Oct 29, 2024
pulisher
Oct 21, 2024

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence - The Manila Times

Oct 21, 2024
pulisher
Oct 14, 2024

Renaissance Technologies LLC Boosts Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World

Oct 14, 2024
pulisher
Oct 12, 2024

Exagen Insider Stock Sales Prove Timely As Market Valuation Descends To US$47m - Simply Wall St

Oct 12, 2024
pulisher
Oct 01, 2024

Stonepine Capital Management LLC Has $653,000 Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Exagen Inc. (NASDAQ:XGN) Shares Sold by Nantahala Capital Management LLC - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges - Investing.com

Sep 30, 2024
pulisher
Sep 28, 2024

Exagen Inc. (NASDAQ:XGN) Short Interest Up 20.9% in September - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

Octopus Energy acquires solar and storage company Exagen Group - Yahoo Finance

Sep 25, 2024
pulisher
Sep 24, 2024

Octopus buys British solar and battery storage firm Exagen - Reuters

Sep 24, 2024
pulisher
Sep 23, 2024

PARP Inhibitor Biomarkers Market Expected to Reach $1.75 Billion by 2031 - WhaTech

Sep 23, 2024
pulisher
Sep 20, 2024

Autoimmune Disease Diagnostics Market 2024 Global Insights and Business Scenario 2031 - Newstrail

Sep 20, 2024
pulisher
Sep 18, 2024

San Diego 2024 Top Tech Awards ceremony set for Sept. 26 at Snapdragon Stadium - CBS News 8

Sep 18, 2024
pulisher
Sep 18, 2024

Autoimmune Disease Testing Market to Reach $12.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market Research - PR Newswire UK

Sep 18, 2024
pulisher
Sep 13, 2024

Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now - MSN

Sep 13, 2024
pulisher
Sep 13, 2024

Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week - Yahoo Finance

Sep 13, 2024
pulisher
Sep 10, 2024

PARP Inhibitor Biomarkers Market to Surge with 8.8% CAGR by 2031 - WhaTech

Sep 10, 2024
pulisher
Sep 06, 2024

Improved Revenues Required Before Exagen Inc. (NASDAQ:XGN) Stock's 40% Jump Looks Justified - Simply Wall St

Sep 06, 2024
pulisher
Sep 04, 2024

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference - ForexTV.com

Sep 04, 2024
pulisher
Aug 28, 2024

Exagen Inc. (NASDAQ:XGN) Short Interest Down 41.5% in August - MarketBeat

Aug 28, 2024
pulisher
Aug 28, 2024

Short Interest in Exagen Inc. (NASDAQ:XGN) Decreases By 41.5% - Defense World

Aug 28, 2024
pulisher
Aug 26, 2024

Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance

Aug 26, 2024
pulisher
Aug 23, 2024

Matthew G. Brown - Wilson Sonsini

Aug 23, 2024
pulisher
Aug 23, 2024

Detailed Analysis of Personalized Medicine Market Exploring Future Growth Potential, New Developments, Comp... - WhaTech

Aug 23, 2024
pulisher
Aug 19, 2024

XGN (Exagen) EBITDA : $-13.05 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

XGN (Exagen) Debt-to-EBITDA : -3.02 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

XGN (Exagen) Net Income From Continuing Operations : $-17.31 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

XGN (Exagen) Profitability Rank : 2 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

XGN (Exagen) Revenue : $56.66 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

XGN (Exagen) EBITDA per Share : $-0.73 (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

XGN (Exagen) Net-Net Working Capital : $0.09 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

XGN (Exagen) Earnings Yield % : N/A% (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 15, 2024

Reviewing Exagen (NASDAQ:XGN) and BioNexus Gene Lab (NASDAQ:BGLC) - Defense World

Aug 15, 2024
pulisher
Aug 14, 2024

Investing in Exagen Inc (XGN) Is Getting More Attractive - Knox Daily

Aug 14, 2024
pulisher
Aug 14, 2024

Personalized Medicine Market to Reach US$ 1,078.17 Billion - GlobeNewswire

Aug 14, 2024
pulisher
Aug 13, 2024

Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out? - MSN

Aug 13, 2024
pulisher
Aug 13, 2024

SOLVD Health Names Chief Financial Officer and Senior Vice President of Clinical Operations - Business Wire

Aug 13, 2024
pulisher
Aug 09, 2024

Hyper Personalized Medicine Market Recovery and Impact Analysis Report – Dako A/S, Exagen Inc., Abbott - TIMC

Aug 09, 2024
pulisher
Aug 08, 2024

Exagen stock touches 52-week high at $2.75 amid market fluctuations - Investing.com

Aug 08, 2024
pulisher
Aug 08, 2024

Cantor Fitzgerald Research Analysts Lift Earnings Estimates for Exagen Inc. (NASDAQ:XGN) - Defense World

Aug 08, 2024
pulisher
Aug 08, 2024

Fast-paced Momentum Stock Exagen (XGN) Is Still Trading at a Bargain - MSN

Aug 08, 2024
pulisher
Aug 08, 2024

Q3 2024 EPS Estimates for Exagen Inc. Lifted by Analyst (NASDAQ:XGN) - Defense World

Aug 08, 2024
pulisher
Aug 07, 2024

Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 07, 2024
pulisher
Aug 07, 2024

Exagen Inc (XGN) Q2 2024 Earnings Call Transcript Highlights: Re - GuruFocus.com

Aug 07, 2024
pulisher
Aug 07, 2024

Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Second-Quarter Report - Simply Wall St

Aug 07, 2024
pulisher
Aug 07, 2024

Exagen (NASDAQ:XGN) Releases Quarterly Earnings Results, Beats Estimates By $0.20 EPS - Defense World

Aug 07, 2024
pulisher
Aug 07, 2024

Exagen Inc. (NASDAQ:XGN) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 07, 2024
pulisher
Aug 06, 2024

Exagen (NASDAQ:XGN) Issues Quarterly Earnings Results - American Banking and Market News

Aug 06, 2024
pulisher
Aug 06, 2024

Earnings call: Exagen Inc. reports improved financials, upgrades AVISE CTD - Investing.com

Aug 06, 2024
pulisher
Aug 05, 2024

XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace

Aug 05, 2024
pulisher
Aug 05, 2024

Exagen, Inc. (XGN) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 05, 2024
$222.11
price down icon 2.54%
diagnostics_research LH
$228.27
price down icon 0.99%
diagnostics_research WAT
$323.11
price down icon 1.07%
$144.14
price down icon 2.38%
diagnostics_research MTD
$1,291.75
price down icon 0.81%
$406.92
price down icon 9.79%
大文字化:     |  ボリューム (24 時間):